Thus, measurement of 2HG by magnetic resonance spectroscopy could be useful as a metabolic biomarker for mutations in isocitrate dehydrogenase 1 (IDHmut) glioma response to PI3K/mTOR inhibition. The gene discussed is MTOR; the disease is central nervous system cancer.